GlaxoSmithKline Biologicals SA

2 Cited authorities

  1. Section 317 - Settlement

    35 U.S.C. § 317   Cited 37 times   48 Legal Analyses
    Addressing continuation of IPR as to some petitioners after dismissal of others
  2. Section 42.74 - Settlement

    37 C.F.R. § 42.74   Cited 3 times   13 Legal Analyses

    (a)Board role. The parties may agree to settle any issue in a proceeding, but the Board is not a party to the settlement and may independently determine any question of jurisdiction, patentability, or Office practice. (b)Agreements in writing. Any agreement or understanding between the parties made in connection with, or in contemplation of, the termination of a proceeding shall be in writing and a true copy shall be filed with the Board before the termination of the trial. (c)Request to keep separate